EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Sulforaphane activates CD8 + T cells antitumor response through IL-12RB2/MMP3/FasL-induced MDSCs apoptosis’

Jinyan Liu, Huanan Chen, Caijuan Guo, Jieyao Li, Miaomiao Li, Ming Zhao, Ziyi Fu, Zhen Zhang, Feng Li iD, Xuan Zhao, Li Yang, Liping Wang und 2 weitere

Journal for ImmunoTherapy of Cancer · 2024

DOI: 10.1136/jitc-2023-007983 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal for ImmunoTherapy of Cancer, 2024. Verfasst von Jinyan Liu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Biotherapy Center and Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China. Hauptthemen laut MEDLINE: Myeloid-Derived Suppressor Cells, Sulfoxides, Isothiocyanates. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: the National Natural Science Foundation of China, Innovation Team within the First Affiliated Hospital of Zhengzhou University, Henan Province Science and Technology Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Extensive attention has been given to the role of myeloid-derived suppressor cells (MDSCs) in driving tumor progression and treatment failure. Preclinical studies have identified multiple agents that eliminate MDSCs. However, none have been authorized in the cliniccal ues due to the safety reasons. In the present study, we investigated the efficacy and mechanism of sulforaphane (SFN) to eliminate MDSCs in the tumor microenvironment (TME).

Methods

We monitored SFN effect on tumor growth and the percents or apoptosis of immune cell subsets in mice models bearing LLC or B16 cells. Flow cytometry, quantitative reverse transcription-PCR, immunohistochemistry, ELISA, immunofluorescence, imaging flow cytometry and western blot were performed to validate the role of SFN on MDSCs function in vivo and in vitro. RNA sequencing was then used to interrogate the mechanisms of how SFN regulated MDSCs function. Tumor xenograft models were established to evaluate the involvement of IL-12RB2/MMP3/FasL induced MDSCs apoptosis in vivo. We verified the effect of SFN on MDSCs and CD8 + T cells in the blood samples from a phase I clinical trial (KY-2021–0350).

Results

In this study, we elucidated that SFN liberated CD8 + T-cell antitumor ability by reducing MDSCs abundance, leading to repressed tumor growth. SFN treatment suppressed MDSCs accumulation in the peripheral blood and tumor sites of mice, but had no effect on the bone marrow. Mechanistically, SFN activates IL-12RB2, which stimulates the MMP3/FasL signaling cascade to trigger caspase 3 cleavage and induce apoptosis in MDSCs. Clinically, SFN treatment eliminates peripheral MDSCs and increases the percentage and activation of CD8 + T cells.

Conclusions

Collectively, we uncovered the role of SFN in eliminating MDSCs to emancipate CD8 + T cells through IL-12RB2/MMP3/FasL induced apoptosis, thus providing a strategy for targeting MDSCs to control tumors and improve clinical efficacy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myeloid-Derived Suppressor CellsSulfoxidesIsothiocyanatesHumansMiceAnimalsCD8-Positive T-LymphocytesMatrix Metalloproteinase 3Cell Line, TumorApoptosis

Stichwörter der Autor:innen

Adaptive ImmunityMyeloid-Derived Suppressor Cells

Substanzen

sulforaphaneMatrix Metalloproteinase 3MMP3 protein, humanSulfoxidesIsothiocyanates

Autor:innen und Institutionen

  • Biotherapy Center and Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
  • Department of Medical Record Management and Statistics, Shandong Provincial, Qianfoshan Hospital, The First Affiliated Hospital of Shandong First Medical University, Jinan, China.
  • Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
  • Department of Nutrition and Food Hygiene, College of Public Health, and the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China yizhang@zzu.edu.cn lqjnutr@zzu.edu.cn.
  • Biotherapy Center and Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China yizhang@zzu.edu.cn lqjnutr@zzu.edu.cn.
  • State Key Laboratory of Esophageal Cancer Prevention & and Treatment, Zhengzhou, Henan, China.

ORCID-Profile: Feng Li, Yi Zhang

Förderung

  • the National Natural Science Foundation of China
  • Innovation Team within the First Affiliated Hospital of Zhengzhou University
  • Henan Province Science and Technology Research
  • Henan Province Major Public Welfare Projects
  • Healthy Talents Project of Henan Province
  • State's Key Project of Research and Development Plan
  • Henan Province Medical Science and Technology Research Provincial and Ministry Co-constructed Projects
  • Henan Provincial Central Leading Local Science and Technology Development Fund Project

Zitieren

APA

Liu, J., Chen, H., Guo, C., Li, J., Li, M., Zhao, M., Fu, Z., Zhang, Z., Li, F., Zhao, X., Yang, L., Wang, L., Lv, Q., & Zhang, Y. (2024). Sulforaphane activates CD8 + T cells antitumor response through IL-12RB2/MMP3/FasL-induced MDSCs apoptosis’. Journal for ImmunoTherapy of Cancer. https://doi.org/10.1136/jitc-2023-007983

Vancouver

Liu J, Chen H, Guo C, Li J, Li M, Zhao M, et al. Sulforaphane activates CD8 + T cells antitumor response through IL-12RB2/MMP3/FasL-induced MDSCs apoptosis’. Journal for ImmunoTherapy of Cancer. 2024. doi:10.1136/jitc-2023-007983

BibTeX
@article{Liu2024,
  author = {Liu, Jinyan and Chen, Huanan and Guo, Caijuan and Li, Jieyao and Li, Miaomiao and Zhao, Ming and Fu, Ziyi and Zhang, Zhen and Li, Feng and Zhao, Xuan and Yang, Li and Wang, Liping and Lv, Quanjun and Zhang, Yi},
  title = {Sulforaphane activates CD8 + T cells antitumor response through IL-12RB2/MMP3/FasL-induced MDSCs apoptosis’},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2024},
  doi = {10.1136/jitc-2023-007983}
}
Kostenlos starten →